Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease

W. Kim, B. G. Kim, J. S. Lee, C. K. Lee, J. E. Yeon, M. S. Chang, J. H. Kim, H. Kim, S. Yi, J. Lee, J. Y. Cho, S. G. Kim, J. H. Lee, Y. J. Kim

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease'. Together they form a unique fingerprint.

Medicine & Life Sciences